NumFin

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

符号: 2196.HK

HKSE

13.28

HKD

今天的市场价格

  • 15.5749

    市盈率

  • 7.2266

    PEG比率

  • 63.71B

    MRK市值

  • 0.04%

    DIV收益率

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196-HK) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

balance-sheet.row.cash-and-short-term-investments

015582.117169.814549.2
11931.9
9989.9
9162.6
7468.2
6044.5
4062.4
3729.5
3111.6
5197.4
3125.9
3562.3
1308.5
1005.7
1079.6
991.3
752.9
688.1
1242.6
629.4
373.1
343.4
170
329.8
25.3
6.6
7.2

balance-sheet.row.short-term-investments

01888.5928.54241.1
1970.1
456.7
616.1
219.3
48.5
33.8
33.8
44.2
224.8
231.3
218.8
11.7
0.1
5.8
2.1
0
5.2
0.2
285.3
0.9
0
0
0
0
0
0

balance-sheet.row.net-receivables

09967.910797.89517.7
7256.7
5873.4
5255.7
4522.5
2976.9
2518.7
3318.7
2256.4
1906.4
1797.3
1426.6
925.2
940.2
732.1
811
673.6
618.3
536.6
406.4
545.2
37.5
58.4
31.4
9.1
5.1
26.3

balance-sheet.row.inventory

07537.86882.45472.3
5162.8
3940.5
3287.4
2750.5
1670.7
1648.8
1604.6
1614.3
1273.4
1123.9
934.4
598
530.5
494.8
607.6
532
472.8
305.1
355.3
120.5
82.8
85
52.3
49.6
18
12.5

balance-sheet.row.other-current-assets

0704.8429.1885.4
733.4
599.5
296
315.3
72.1
95.5
11.2
4.2
4.3
1.9
14.3
475.2
-59.2
210.6
6.5
3.3
0.5
19
16.1
6
207.7
117
96.6
132.7
77
57.4

balance-sheet.row.total-current-assets

033792.635279.230424.6
25084.8
20403.4
18001.7
15056.5
10764.3
8325.4
8664
6986.5
8381.5
6049.1
5937.7
3306.9
2417.3
2517.1
2416.4
1961.9
1779.7
2103.4
1407.2
1044.9
671.4
430.5
510.1
216.7
106.7
103.4

balance-sheet.row.property-plant-equipment-net

022239.416028.113283.9
13002.7
11085.1
9123.1
8315.9
6304.7
5764.9
5681.4
4907.5
3479.7
2627.3
1695.7
1258.8
1145.3
1139.1
1274.4
1240.6
1054
777.2
570.5
349.4
260.6
175.5
74.4
41.6
4.4
3.3

balance-sheet.row.goodwill

01085210337.19400
8677.2
9014
8853.9
8464.3
3473.1
3303.4
3255
2976
1661.8
1585.1
296.4
51.1
51.1
51.1
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

017378.115925.313433.2
11498.6
10966.2
9192.1
8274.5
3650.6
3245.8
2911.9
2639.4
1782.3
1705.1
533.9
209
200.1
208.4
210.3
197.5
179
114.6
97.9
39.3
48
20.7
0.9
0.5
0
0

balance-sheet.row.goodwill-and-intangible-assets

028230.126262.422833.1
20175.9
19980.2
18046
16738.8
7123.7
6549.2
6166.9
5615.5
3444
3290.2
830.3
260.1
251.2
259.6
210.3
197.5
179
114.6
97.9
39.3
48
20.7
0.9
0.5
0
0

balance-sheet.row.long-term-investments

023123.824620.519679
21801.2
22564
23443.5
20904.5
18801.5
17200.5
14371.1
11560.7
9822.5
10011.5
7960.7
6652.3
3683.8
3465.1
2704.8
0
2108.4
1187.1
741.6
760.6
570.3
219.3
46.1
1.7
0
0

balance-sheet.row.tax-assets

0624.5442.6265.6
244.9
196.1
173.1
144.5
129.6
102.5
101.2
88.1
31.5
16.7
18.4
11.4
12.9
11.8
5.6
0
20.1
36.5
322.4
15.5
-555.5
-211.5
10.6
10.3
0
0

balance-sheet.row.other-non-current-assets

05459.34531.26807.4
3376.5
1890.9
1763.9
810.8
644
259.3
351.6
316.9
347.9
295.9
377.5
37.6
28.5
42.3
22.3
2268.7
29.4
0
0
-2.4
576.3
223.8
4.9
16.3
0.2
0

balance-sheet.row.total-non-current-assets

07967771884.762869.2
58601.2
55716.3
52549.6
46914.5
33003.5
29876.3
26672.3
22488.6
17125.6
16241.7
10882.5
8220.2
5121.6
4917.9
4217.5
3706.8
3390.8
2115.5
1732.4
1162.4
899.7
427.8
137
70.4
4.6
3.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0113469.6107163.993293.8
83686
76119.6
70551.4
61971
43767.8
38201.7
35336.3
29475.2
25507.1
22290.8
16820.1
11527.1
7538.9
7435
6633.9
5668.7
5170.5
4218.8
3139.6
2207.3
1571.1
858.2
647.1
287.1
111.3
106.7

balance-sheet.row.account-payables

06159.662845063.7
3289
2397.3
2333.3
1781.9
1149.4
1048.6
905
1136.4
903.7
939.9
827.3
491.3
398
357.8
530.9
560.3
484
339.3
326.3
89.5
70.5
63.6
36.9
50.8
10.8
5.7

balance-sheet.row.short-term-debt

019555.117402.914547.6
14911.8
8920.5
10536.8
10478.2
5650.4
7334.2
3950.7
1424.2
875.3
2187.1
1830.4
1583
502.5
1556.4
1465.2
786.3
682
466.3
772.3
627.5
129.7
39.6
0
22.5
29.5
21

balance-sheet.row.tax-payables

0537929.8727.5
564.7
759.6
478.9
480.1
478.2
503.8
342.9
288.9
162
111.7
247.4
48.9
49.5
73.7
42.1
27.8
38
62.6
61.3
9.5
16.2
8
12.1
10.4
0
-0.1

balance-sheet.row.long-term-debt-total

015554.512844.99697.4
9103
12987.1
12670.1
9814.9
5571
3571.5
3856.7
4199.7
4280.2
3915.1
2758.3
1284.5
1180.5
746.8
545.1
981.2
752.8
1026.9
45.8
25.2
25.2
13.8
30.1
0.5
0.4
14.3

Deferred Revenue Non Current

0639.4632.4512.8
482.2
417.3
363.5
397.1
346.7
169.3
139.6
404.5
627.6
374.2
57.8
64.9
65.2
70.1
-449
-877.5
5.1
5.9
-38.8
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0125.29611.21528.6
54.6
249
4574.3
604.6
944.9
352.8
1337.1
309.5
729.9
221.9
110.6
67.6
541.3
44.1
18.8
40.1
33.6
34.1
32
27
16.4
9.2
37.3
0.6
22.7
34.1

balance-sheet.row.total-non-current-liabilities

023095.819756.915608.3
12829.4
19481.7
19035.4
15629.1
8408.9
6592.9
6696
6532.6
6309.3
5928.3
3723.4
2076.8
1337.8
900.5
642.4
1087.7
762.7
1035.3
53.9
25.2
27.9
13.8
42.1
0.5
0.4
14.8

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

02049.6745648.4
627.3
410.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

056853.35305544918.2
37701.7
36915.4
36958.6
32229.6
18517.5
17532.1
16233.3
11810.7
10202.5
10920
7426.9
4575.1
3093
3118.6
2985.3
2793.7
2356.7
2201.9
1466.2
884.7
352.6
201.1
116.4
154.5
79.3
81.1

balance-sheet.row.preferred-stock

01300.11198.41265.8
933.6
468
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

02672.42672.22562.9
2562.9
2562.9
2563.1
2495.1
2414.5
2314.1
2311.6
2240.5
2240.5
1904.4
1904.4
1237.8
1237.8
1237.8
952.1
832
826.5
381.9
381.9
293.8
293.8
226.1
150.7
58.8
20
20

balance-sheet.row.retained-earnings

024542.523216.921039.6
17505
15125.7
12771.5
11111.6
8993.8
6937
5457
7112.7
5703
4483.5
3717.7
3258.2
1184.8
715.1
262.9
349.3
411.3
372.5
182.1
143.4
108.6
114.4
46.8
27.5
6.2
2.9

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-1300.1-1198.4-1265.8
-933.6
-468
-4436.3
-4000.5
-3047.9
-2592.5
-2164.5
-1671.5
-1213.5
-1061.4
-871.5
-654.1
-544.9
-478
0
-9
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

018469.918693.415589.5
16927.7
14199.5
17079.5
15720.6
13829.8
11523
11070.7
7650.6
6828.8
4445.4
3672.4
2634.7
2131.2
2397.4
1875.2
1218.6
1066.4
945.8
845.5
826.8
743.2
264.1
321.7
14.4
5.7
2.7

balance-sheet.row.total-stockholders-equity

045684.844582.539191.9
36995.5
31888.1
27977.7
25326.9
22190.2
18181.6
16674.8
15332.2
13558.8
9771.9
8423
6476.5
4008.9
3872.3
3090.2
2390.9
2304.1
1700.2
1409.5
1264
1145.5
604.5
519.1
100.7
32
25.6

balance-sheet.row.total-liabilities-and-stockholders-equity

0113469.6107163.993293.8
83686
76119.6
70551.4
61971
43767.8
38201.7
35336.3
29475.2
25507.1
22290.8
16820.1
11527.1
7538.9
7435
6633.9
5668.7
5170.5
4218.8
3139.6
2207.3
1571.1
858.2
647.1
287.1
111.3
106.7

balance-sheet.row.minority-interest

010931.59526.59183.6
8988.7
7316.1
5615
4414.6
3060.1
2488.1
2428.2
2332.3
1745.9
1599
970.2
475.5
437.1
444.1
558.3
484.2
509.7
316.7
263.9
58.7
73
52.6
11.6
32
0
0

balance-sheet.row.total-equity

056616.354108.948375.6
45984.3
39204.2
33592.7
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

025012.325549.123920.1
23771.3
23020.6
24059.6
21123.8
18850
17234.2
14404.9
11604.9
10047.3
10242.8
8179.4
6664
3683.9
3471
2706.9
2227.2
2113.6
1187.3
1026.9
760.6
570.3
219.3
46.1
1.7
0
0

balance-sheet.row.total-debt

035109.630247.724245
24014.8
21907.6
23206.9
20293.1
11221.3
10905.7
7807.4
5623.9
5155.5
6102.1
4588.7
2867.5
1683
2303.2
2010.3
1767.5
1434.8
1493.2
818.1
652.6
154.9
39.6
30.1
22.5
29.5
35.4

balance-sheet.row.net-debt

02141614006.413936.9
14053
12374.4
14660.4
13044.2
5225.3
6877.1
4111.7
2556.5
183
3207.6
1245.2
1570.8
677.3
1229.4
1021.1
1014.6
752
250.8
474
280.4
-188.5
-130.4
-299.7
-2.8
22.9
28.2

现金流量表

在 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

02895.13947.54987.4
3940
3743.5
3019.9
3585.3
3221.3
2870.7
2369.8
2399.9
1839.3
1384.8
1000.3
2564.3
760.9
690.2
292.8
237.9
282.1
298.2
161.7
141.1
135.8
94.4
64.9

cash-flows.row.depreciation-and-amortization

02965.22335.91834.4
1666.2
1472.1
1320.1
938.6
732.9
649.3
558.4
415.5
286.2
209.9
152.7
134.7
132.5
136.5
132.1
116.7
91.1
56.1
37.6
28.6
28.1
20.1
9.3

cash-flows.row.deferred-income-tax

0-2723.50-4038.6
-2605.1
-2733
-1876.1
-2322.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

035.954.564.3
55.2
109.1
72.3
10.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-1081.2-1387.9259.7
-1401.4
-494.6
-535.1
-212.7
-288.1
-101.8
-555.3
-44.5
-28.2
-88.6
11
599.1
13.6
-133.7
-5.4
-107
789.2
23.2
-35
-45.2
0.8
-78
-10.8

cash-flows.row.account-receivables

01605.1-2076.6-1795
-1559.9
-863.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-333.9-1430.1-464.7
-1253.4
-505.2
-564.7
-491.1
-65.4
-88.3
-105
-149.6
-155.1
-99.8
-66.2
-70.1
-27.6
109.6
-42.7
-67
-27
56
-11.2
-37.5
12.4
-14.4
-4.9

cash-flows.row.account-payables

0-1605.12076.61795
1559.9
863.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-2352.442.2724.5
-148
10.6
29.6
278.4
-222.7
-13.4
-450.3
105.1
126.9
11.2
77.2
669.2
41.2
-243.3
37.2
-40
816.2
-32.8
-23.8
-7.7
-11.6
-63.6
-5.9

cash-flows.row.other-non-cash-items

01322.7-732.4841.5
924.9
1125.3
949
580.8
-1556.1
-1797.2
-1172.7
-1759.4
-1431.8
-1189.5
-960.6
-3036.2
-673.9
-561.5
-234.6
-59.3
-957.3
-227.3
-61.8
-56.3
-26.3
1.7
3.2

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-5336.7-5888.8-4972.6
-4437.1
-3962.1
-3174.9
-2170.6
-1922
-1235.5
-1119.4
-1040.1
-1160.6
-796.8
-339.2
-348.1
-210.6
-209.7
-266.6
-222.6
-205
-264.1
-139.5
-141.5
-126.6
-78
-52.2

cash-flows.row.acquisitions-net

0-923.7-487.6381.4
-140.3
-818.8
-622.6
-7822.6
-249.4
109.9
-1145.7
-2225.2
30.8
12.7
2.1
-2.6
22.8
9.3
18.2
279.9
11.6
25.5
4.9
10.8
17.6
1
0

cash-flows.row.purchases-of-investments

0-943-1501.3-1424.6
-1070.1
-517.9
-2133.4
-2525.7
-1395.7
-2955.3
-1943.2
-364.1
-759.1
-1500.3
-1190.2
-770.2
-563.2
-543.7
-399.3
-349
-665.1
-134.9
-475.3
-317.8
-345.5
-253.5
-46

cash-flows.row.sales-maturities-of-investments

02809.34649.52168.3
2037.2
4916.2
1243.4
1550.6
1492.6
2127
1515.9
1540.7
1484.7
615.5
1348
755.5
822.8
632.3
329.6
76.6
45.4
535.7
254.8
243.5
30.2
43.4
0.4

cash-flows.row.other-investing-activites

0574.8-835.9-9.5
-1095.8
210.6
-557.4
464.2
-372.6
83.9
214.2
285.2
-574.4
-97.6
-85
-32.5
-15.6
58
-17
-222.6
33.9
-0.2
204.6
-282
-19.3
48.2
-2

cash-flows.row.net-cash-used-for-investing-activites

0-3819.3-4064-3857
-4706.2
-172
-5244.9
-10504.1
-2447.1
-1869.9
-2478.3
-1803.5
-978.6
-1766.5
-264.3
-397.8
56.1
-53.7
-335.1
-437.7
-779.2
162.1
-150.5
-487.1
-443.6
-238.9
-99.8

cash-flows.row.debt-repayment

0-21146.2-26280.1-27391.9
-15707.8
-13942.1
-9995.1
-9085.3
-9956.1
-7239.7
-2559.5
-2417.6
-3795.9
-4042.2
-2081.7
-1071.9
-1410.2
-1753.9
-1221
-817.9
-727.4
-665.6
-1613.8
-716.1
-311.2
-62.8
-52.4

cash-flows.row.common-stock-issued

0000
0
0
4851.4
3017.6
2728.5
116.1
1466.1
30.5
3151.1
0
637.8
18.9
16.1
17.2
0
0
9
951.5
8.4
6.7
437.6
0
372.4

cash-flows.row.common-stock-repurchased

0000
0
0
0
14821.2
7694.5
8990.2
4017.4
2105.1
-17.8
0
3083.4
1703.6
1286
2100.3
0
0
873.7
-589.4
1691
1200.8
-48.5
0
-342.4

cash-flows.row.dividends-paid

0-2455.2-2374.4-1914
-1834.6
-1864.4
-1775.5
-1433.5
-1193.5
-1109.3
-962.7
-804.5
-500.9
-437.3
-297.4
-268.6
-257.9
-237.6
-371.9
-200
-149.2
-94.9
-89.8
-78.2
-14.1
-13.4
-9.7

cash-flows.row.other-financing-activites

022265.13308328474.6
19009.5
13870.5
10056.8
2588.7
2172.7
-206.6
-98.3
154.3
3231.9
5392.5
480.3
18.9
16.1
17.2
1963.6
1165.7
8.5
984.4
24.1
41
402.5
117.1
369.8

cash-flows.row.net-cash-used-provided-by-financing-activities

0-1336.24428.5-831.3
1467.1
-1936
3137.5
9908.6
1446
550.7
1863.1
-932.1
2068.4
913
1822.5
401
-349.9
143.1
370.7
147.8
14.6
586.1
19.9
454.2
466.3
41
337.7

cash-flows.row.effect-of-forex-changes-on-cash

073.6128.3-134.7
-300.2
-5.1
-18
-172.5
80.5
36.6
8.9
-31.4
-12
-6
-3.8
-0.7
-4.6
-4.8
-1.2
-0.4
0
-0.1
0
0
0.1
0
0

cash-flows.row.net-change-in-cash

0-1667.74710.3-874.2
-959.5
1109.4
824.7
1812.3
1189.4
338.4
593.9
-1755.3
1743.4
-542.9
1757.7
264.3
-65.4
216.1
219.3
-102
-559.5
898.3
-28.2
35.3
161.2
-159.7
304.5

cash-flows.row.cash-at-end-of-period

09502.411170.16450.7
7324.9
8284.4
7175
6350.3
4538
3348.6
3010.2
2416.3
4171.6
2428.2
2971.1
1213.4
949.1
1014.4
800.2
580.9
682.9
1242.4
344.1
372.3
343.4
170
329.8

cash-flows.row.cash-at-beginning-of-period

011170.16459.77324.9
8284.4
7175
6350.3
4538
3348.6
3010.2
2416.3
4171.6
2428.2
2971.1
1213.4
949.1
1014.4
798.4
580.9
682.9
1242.4
344.1
372.3
337
182.2
329.8
25.3

cash-flows.row.operating-cash-flow

03414.24217.63948.7
2579.8
3222.4
2950.1
2580.2
2110
1621
1200.2
1011.6
665.5
316.6
203.4
261.9
233
131.5
184.9
188.3
205.1
150.1
102.5
68.2
138.4
38.2
66.6

cash-flows.row.capital-expenditure

0-5336.7-5888.8-4972.6
-4437.1
-3962.1
-3174.9
-2170.6
-1922
-1235.5
-1119.4
-1040.1
-1160.6
-796.8
-339.2
-348.1
-210.6
-209.7
-266.6
-222.6
-205
-264.1
-139.5
-141.5
-126.6
-78
-52.2

cash-flows.row.free-cash-flow

0-1922.5-1671.3-1023.8
-1857.3
-739.6
-224.8
409.6
188.1
385.5
80.8
-28.4
-495.1
-480.2
-135.8
-86.2
22.4
-78.2
-81.7
-34.3
0.1
-113.9
-37
-73.4
11.8
-39.8
14.3

利润表行

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 的收入与上期相比变化了 NaN%。据报告, 2196.HK 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

income-statement-row.row.total-revenue

041399.543951.539005.1
30307
28585.2
24918.3
18533.6
14628.8
12608.6
12025.5
9996.4
7340.8
6485.5
4555.4
3872.3
3773.2
3693.3
3102
2988.5
2425.4
2154.6
1031.7
727.8
579.5
442.5
340.4
190.3
92.7
64.7

income-statement-row.row.cost-of-revenue

021595.323169.720228.3
13431.2
11543.4
10365.3
7609
6718.4
6308
6718.6
5543.4
4126.8
3991.1
2984.6
2610.7
2711.9
2693.8
2282.2
2076
1651.9
1564
668.1
448.9
307.6
248.4
209.3
116.5
65.3
50.1

income-statement-row.row.gross-profit

019804.220781.918776.8
16875.8
17041.7
14553
10924.6
7910.5
6300.6
5307
4453
3214
2494.4
1570.9
1261.6
1061.4
999.5
819.8
912.5
773.6
590.5
363.6
279
271.9
194
131.1
73.9
27.3
14.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-17.92683.72276.4
1841.5
1666
44.1
-13.2
181.9
78.3
324.6
97.9
89.9
158.8
62.1
56
30.9
21.9
60.5
96.5
52.8
42.7
18.1
12.3
18.9
10.9
8
10
-0.3
0.5

income-statement-row.row.operating-expenses

018240.91714516055.8
14045.6
14425.7
12185.7
8621
6168.5
4827.1
4114.5
3339.1
2620.4
2149
1394.5
1098.2
939.7
834.5
794.6
829.5
658.2
549.4
304.1
206.9
172.3
102.3
62.6
31.6
14.3
4.9

income-statement-row.row.cost-and-expenses

039836.240314.736284.1
27476.8
25969.1
22551
16230
12886.8
11135.2
10833.1
8882.5
6747.2
6140.2
4379.1
3708.8
3651.6
3528.3
3076.7
2905.5
2310.1
2113.4
972.2
655.7
480
350.7
271.9
148.1
79.6
55

income-statement-row.row.interest-income

0363.6282.6233.7
199.6
186.6
145.7
79.2
80.9
56.2
69.8
63.8
29.7
51.6
19.6
14.5
17.9
12.5
13.8
17.5
13.7
8.7
2.9
13.7
8.1
0
0
0
0
0

income-statement-row.row.interest-expense

01324.8963.8822.5
881
1074.7
929.7
577.5
488.2
470
415
350.5
370.6
314
162.4
132.4
149.6
130.6
83.3
72
37
45.9
36.2
23.7
9.8
-6.1
-3.3
3.1
3
1.5

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-42.9-3722.2-259.9
-43.3
-1887.5
1212.3
1758.1
1829.5
1898.4
1525.6
1792.3
1529.5
1381.3
1025.6
3101.2
714
591.4
249.1
124.7
159.4
282.5
104.1
76.8
42.6
12.8
5.2
-3.1
-3.1
-1.4

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-17.92683.72276.4
1841.5
1666
44.1
-13.2
181.9
78.3
324.6
97.9
89.9
158.8
62.1
56
30.9
21.9
60.5
96.5
52.8
42.7
18.1
12.3
18.9
10.9
8
10
-0.3
0.5

income-statement-row.row.total-operating-expenses

0-42.9-3722.2-259.9
-43.3
-1887.5
1212.3
1758.1
1829.5
1898.4
1525.6
1792.3
1529.5
1381.3
1025.6
3101.2
714
591.4
249.1
124.7
159.4
282.5
104.1
76.8
42.6
12.8
5.2
-3.1
-3.1
-1.4

income-statement-row.row.interest-expense

01324.8963.8822.5
881
1074.7
929.7
577.5
488.2
470
415
350.5
370.6
314
162.4
132.4
149.6
130.6
83.3
72
37
45.9
36.2
23.7
9.8
-6.1
-3.3
3.1
3
1.5

income-statement-row.row.depreciation-and-amortization

02965.22335.92986.4
2171.8
1472.1
1320.1
938.6
732.9
649.3
558.4
415.5
286.2
209.9
152.7
134.7
132.5
136.5
132.1
116.7
91.1
56.1
37.6
28.6
28.1
20.1
9.3
-7
3.3
1

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

03307.58296.66313.7
4721.1
6413.2
3535.5
4074.9
3399.4
3297.2
2394.3
2818.8
2036
1580.5
1140.5
3212
807.6
736.7
347.1
234.5
298.2
329.4
168.5
144.1
141.9
106.3
77.3
49.3
9.8
8.7

income-statement-row.row.income-before-tax

03264.64574.46053.8
4677.8
4525.8
3579.6
4061.7
3571.5
3371.8
2718.1
2906.3
2123
1726.7
1202
3264.7
835.7
756.4
341
269.3
312.9
347.8
175.1
152.7
151.4
110.9
79.5
49.3
9.7
8.7

income-statement-row.row.income-tax-expense

0369.5626.91066.4
737.9
782.2
559.7
476.5
350.2
501.2
348.2
506.3
283.8
341.8
201.6
700.4
74.7
66.2
48.2
31.4
30.8
49.6
13.6
11.6
15.7
16.5
12.9
9.1
3.4
2.7

income-statement-row.row.net-income

02386.33730.84728.7
3662.8
3321.6
2707.9
3124.5
2805.8
2460.1
2112.9
2027.1
1563.9
1165.6
863.7
2498.2
690.9
625.8
259.2
159
215.3
263.6
147.2
135.5
128.5
92.2
63.7
36
6.4
6
类似股票
您可能还对以下内容感兴趣：
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
532.5 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
848.1 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.83 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1001.35 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13700 KRW
KSC

常见问题

什么是 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) 总资产是多少？

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) 总资产为 113469604813.000.

什么是企业年收入？

年收入为 N/A.

企业利润率是多少？

公司利润率为 0.475.

什么是公司自由现金流？

自由现金流为 -0.539.

什么是企业净利润率？

净利润率为 0.049.

企业总收入是多少？

总收入为 0.071.

什么是 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 2386265813.000.

公司总债务是多少？

债务总额为 35109563838.000.

营业费用是多少？

运营支出为 18240906770.000.

公司现金是多少？

企业现金为 0.000.